Relationship between circulating concentration of Ang II, ADM and ADT and left ventricular hypertrophy in hypertension
- PMID: 31217886
- PMCID: PMC6556659
Relationship between circulating concentration of Ang II, ADM and ADT and left ventricular hypertrophy in hypertension
Abstract
Background: Left ventricular hypertrophy (LVH) is the most common structural damage in hypertensive complication and is an independent risk factor for assessing cardiovascular events. The aim of this study was explore the relationship between plasma concentration of angiotensin II (Ang II), Adrenomedulin (ADM) and adrenotensin (ADT) in patients with hypertension and LVH.
Methods: We enrolled 310 hypertensive patients from the department of cardiology of Tianjin Union Medical Center as the hypertension group and 39 healthy subjects as control group. Further grouping according to the LVMI (male LVMI≥115 g/m2, female LVMI≥95 g/m2) values for determining LVH in the 2013 ESC Hypertension Management Guidelines. Plasma levels of Ang II, ADM and ADT were measured using ELISA assay.
Results: The levels of plasma Ang II and ADM in essential hypertension (EH) were significantly higher than control group, and the essential hypertension combined left ventricular hypertrophy (EHCLVH) group was higher than essential hypertension not with left ventricular hypertrophy (EHNLVH) group (P<0.05). Correlation analyze showed that left ventricular mass index (LVMI) was positively related to Ang II and ADM, and negatively related to ADT. Logistic regression analyze indicated that LVH are strongly linked with systolic blood pressure (SBP), Ang II, ADM and ADT. ROC curve showed ADM and ADT have similar value in distinguish LVH.
Conclusion: Plasma levels of Ang II, ADM and ADT might act as indicator to identify hypertensive LVH.
Keywords: Hypertension; adrenomedulin; adrenotensin; angiotensin II; left ventricular hypertrophy.
Conflict of interest statement
None.
Figures
Similar articles
-
[Study on changes of plasma substance P in essential hypertension with left ventricular hypertrophy patients and the effect of promoting blood circulation and eliminating phlegm].Zhongguo Zhong Xi Yi Jie He Za Zhi. 1998 Jun;18(6):336-8. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1998. PMID: 11477905 Chinese.
-
Relationships of Blood Pressure Circadian Rhythm and Brain Natriuretic Peptide with Left Ventricular Hypertrophy in the Patients with Primary Hypertension.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Oct 10;38(5):514-521. doi: 10.3881/j.issn.1000-503X.2016.05.004. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 27825406
-
Effect of telmisartan on the regression of the left ventricular hypertrophy in the patients of essential hypertension.J Clin Diagn Res. 2013 Jul;7(7):1352-5. doi: 10.7860/JCDR/2013/5416.3127. Epub 2013 Jul 1. J Clin Diagn Res. 2013. PMID: 23998064 Free PMC article.
-
The importance of left ventricular hypertrophy in human hypertension.J Hypertens Suppl. 1998 Sep;16(7):S23-9. J Hypertens Suppl. 1998. PMID: 9855028 Review.
-
Assessment of prevalence of left ventricular hypertrophy in hypertension.J Hypertens. 1998 Jun;16(6):715-23. doi: 10.1097/00004872-199816060-00001. J Hypertens. 1998. PMID: 9663910 Review.
Cited by
-
Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension.ACS Omega. 2022 Jun 20;7(26):22754-22772. doi: 10.1021/acsomega.2c02277. eCollection 2022 Jul 5. ACS Omega. 2022. PMID: 35811894 Free PMC article.
References
-
- Shenasa M, Shenasa H. Hypertension, left ventricular hypertrophy, and sudden cardiac death. Int J Cardiol. 2017;237:60–63. - PubMed
-
- Kim TH, Yang PS, Yu HT, Jang E, Shin H, Kim HY, Uhm JS, Kim JY, Sung JH, Pak HN, Lee MH, Joung B, Lip GYH. Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population. Eur Heart J. 2019;40:809–819. - PubMed
-
- Cuspidi C, Rescaldani M, Sala C, Grassi G. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014;32:16–25. - PubMed
-
- Rowlands DB, Glover DR, Ireland MA, McLeay RA, Stallard TJ, Watson RD, Littler WA. Assessment of left-ventricular mass and its response to antihypertensive treatment. Lancet. 1982;1:467–470. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous